Skip to main navigation Skip to search Skip to main content

Antiviral profiling of alphavirus inhibitors

Project: Research project

Project Details

StatusFinished
Effective start/end date12/1/17 → 7/31/19

Funding

  • VenatoRx Pharmaceuticals, Inc ( Award #1R44AI122421): $34,540.00